mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
9e-05 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
0.0001 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
0.0001 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
0.0001 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |